Sean Oldham is a seasoned medical science director with extensive experience in oncology, currently serving at Merck since September 2022, where contributions include supporting the launch of Keytruda for NSCLC and providing medical education on pembrolizumab strategies. Prior roles include Director of Medical Affairs at Elevation Oncology, focusing on seribantumab for Nrg1 fusions, and Senior Medical Science Liaison at Takeda Oncology, where support encompassed multiple drug launches. Sean's background also features roles at ARIAD Pharmaceuticals, Meridius Health Communications, and Sanford Burnham Prebys Medical Discovery Institute, alongside a Ph.D. in Pharmacology-Molecular Genetics of Oncology from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices